These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 37150489

  • 21. Real-world Effectiveness of Biologic Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany.
    Li N, Betts KA, Messali AJ, Skup M, Garg V.
    Clin Ther; 2017 Aug; 39(8):1618-1627. PubMed ID: 28729087
    [Abstract] [Full Text] [Related]

  • 22. Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs: a systematic literature review and meta-analysis.
    Gossec L, Humphries B, Rutherford M, Taieb V, Willems D, Tillett W.
    Arthritis Res Ther; 2024 Feb 15; 26(1):50. PubMed ID: 38360699
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis.
    Ruyssen-Witrand A, Perry R, Watkins C, Braileanu G, Kumar G, Kiri S, Nott D, Liu-Leage S, Hartz S, Sapin C.
    RMD Open; 2020 Feb 15; 6(1):. PubMed ID: 32094304
    [Abstract] [Full Text] [Related]

  • 24. The effect of non-TNF-targeted biologics on vascular dysfunction in rheumatoid arthritis: A systematic literature review.
    Ursini F, Ruscitti P, Caio GPI, Manfredini R, Giacomelli R, De Giorgio R.
    Autoimmun Rev; 2019 May 15; 18(5):501-509. PubMed ID: 30844558
    [Abstract] [Full Text] [Related]

  • 25. Biologic therapies and bone loss in rheumatoid arthritis.
    Zerbini CAF, Clark P, Mendez-Sanchez L, Pereira RMR, Messina OD, Uña CR, Adachi JD, Lems WF, Cooper C, Lane NE, IOF Chronic Inflammation and Bone Structure (CIBS) Working Group.
    Osteoporos Int; 2017 Feb 15; 28(2):429-446. PubMed ID: 27796445
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
    Kerschbaumer A, Sepriano A, Bergstra SA, Smolen JS, van der Heijde D, Caporali R, Edwards CJ, Verschueren P, de Souza S, Pope JE, Takeuchi T, Hyrich KL, Winthrop KL, Aletaha D, Stamm TA, Schoones JW, Landewé RBM.
    Ann Rheum Dis; 2023 Jan 15; 82(1):95-106. PubMed ID: 36368906
    [Abstract] [Full Text] [Related]

  • 27. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
    Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, McInnes IB, Sepriano A, van Vollenhoven RF, de Wit M, Aletaha D, Aringer M, Askling J, Balsa A, Boers M, den Broeder AA, Buch MH, Buttgereit F, Caporali R, Cardiel MH, De Cock D, Codreanu C, Cutolo M, Edwards CJ, van Eijk-Hustings Y, Emery P, Finckh A, Gossec L, Gottenberg JE, Hetland ML, Huizinga TWJ, Koloumas M, Li Z, Mariette X, Müller-Ladner U, Mysler EF, da Silva JAP, Poór G, Pope JE, Rubbert-Roth A, Ruyssen-Witrand A, Saag KG, Strangfeld A, Takeuchi T, Voshaar M, Westhovens R, van der Heijde D.
    Ann Rheum Dis; 2020 Jun 15; 79(6):685-699. PubMed ID: 31969328
    [Abstract] [Full Text] [Related]

  • 28. [Targeted and biological drugs in the treatment of inflammatory rheumatic diseases].
    Pavelka K.
    Vnitr Lek; 2021 Jun 15; 67(4):195-200. PubMed ID: 34275303
    [Abstract] [Full Text] [Related]

  • 29. Biologic efficacy optimization--a step towards personalized medicine.
    Kiely PD.
    Rheumatology (Oxford); 2016 May 15; 55(5):780-8. PubMed ID: 26424837
    [Abstract] [Full Text] [Related]

  • 30. Real-world effectiveness of golimumab in the treatment of patients with active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who failed initial TNF-α inhibitor therapy: a pooled analysis of European prospective observational studie.
    Govoni M, Batalov A, Boumpas DT, D'Angelo S, De Keyser F, Flipo RM, Kellner H, Leroi H, Khalifa A.
    Clin Exp Rheumatol; 2024 Mar 15; 42(3):642-650. PubMed ID: 37976120
    [Abstract] [Full Text] [Related]

  • 31. Risk of flare after tapering or withdrawal of biologic/targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis or axial spondyloarthritis: a systematic review and meta-analysis.
    Uhrenholt L, Christensen R, Dinesen WKH, Liboriussen CH, Andersen SS, Dreyer L, Schlemmer A, Hauge EM, Skrubbeltrang C, Taylor PC, Kristensen S.
    Rheumatology (Oxford); 2022 Aug 03; 61(8):3107-3122. PubMed ID: 34864896
    [Abstract] [Full Text] [Related]

  • 32. Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
    Ramiro S, Radner H, van der Heijde D, van Tubergen A, Buchbinder R, Aletaha D, Landewé RB.
    Cochrane Database Syst Rev; 2011 Oct 05; (10):CD008886. PubMed ID: 21975788
    [Abstract] [Full Text] [Related]

  • 33. Tofacitinib Versus Biologic Treatments in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors: Results From a Network Meta-analysis.
    Vieira MC, Zwillich SH, Jansen JP, Smiechowski B, Spurden D, Wallenstein GV.
    Clin Ther; 2016 Dec 05; 38(12):2628-2641.e5. PubMed ID: 27889300
    [Abstract] [Full Text] [Related]

  • 34. Risk of Cancer After Initiation of Targeted Therapies in Patients With Rheumatoid Arthritis and a Prior Cancer: Systematic Review With Meta-Analysis.
    Wetzman A, Lukas C, Gaujoux-Viala C, Mamtani R, Barnetche T, Combe B, Morel J, Szafors P.
    Arthritis Care Res (Hoboken); 2023 Feb 05; 75(2):260-271. PubMed ID: 34549898
    [Abstract] [Full Text] [Related]

  • 35. Biologic rheumatoid arthritis therapies: do we need more comparative effectiveness data?
    Levesque MC.
    BioDrugs; 2012 Apr 01; 26(2):65-70. PubMed ID: 22385403
    [Abstract] [Full Text] [Related]

  • 36. Real-world effectiveness of golimumab in adult patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis and an inadequate response to initial TNFi therapy in Greece: the GO-BEYOND prospective, observational study.
    Athanassiou P, Psaltis D, Georgiadis A, Katsifis G, Theodoridou A, Gazi S, Sidiropoulos P, Tektonidou MG, Bounas A, Kandyli A, Vounotrypidis P, Sakellariou GT, Vassilopoulos D, Huang Z, Petrikkou E, Boumpas D.
    Rheumatol Int; 2023 Oct 01; 43(10):1871-1883. PubMed ID: 37402886
    [Abstract] [Full Text] [Related]

  • 37. Most Appropriate Conventional Disease-Modifying Antirheumatic Drug to Combine With Different Advanced Therapies in Rheumatoid Arthritis: A Systematic Literature Review With Meta-Analysis.
    Decarriere G, Barnetche T, Combe B, Gaujoux-Viala C, Lukas C, Morel J, Daien C.
    Arthritis Care Res (Hoboken); 2021 Jun 01; 73(6):873-884. PubMed ID: 32216091
    [Abstract] [Full Text] [Related]

  • 38. Indirect comparisons of the efficacy of subsequent biological agents in patients with psoriatic arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis.
    Ungprasert P, Thongprayoon C, Davis JM.
    Clin Rheumatol; 2016 Jul 01; 35(7):1795-803. PubMed ID: 26852316
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of non-conventional synthetic DMARDs for patients with rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
    Yuan H, Cui S, Yang L, Cui J, Wang X, Ding M, Jin L, Wang Y, Chang F, Jin H, Ma J, Shi M, Liu A.
    RMD Open; 2023 Oct 01; 9(4):. PubMed ID: 37899093
    [Abstract] [Full Text] [Related]

  • 40. Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation.
    Malottki K, Barton P, Tsourapas A, Uthman AO, Liu Z, Routh K, Connock M, Jobanputra P, Moore D, Fry-Smith A, Chen YF.
    Health Technol Assess; 2011 Mar 01; 15(14):1-278. PubMed ID: 21439251
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.